Sun Nuclear to Showcase Next-Generation Innovations at AAPM & COMP 2026 Annual Meeting

• Daily QA™ 4 Pro for streamlined daily machine quality assurance
• Plan AI™ for treatment planning and AdaptCHECK™ for online adaptive therapy verification
• Clinical presentations and product demonstrations throughout the meeting in Sun Nuclear Booth 800

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, announced today the featured innovations in quality assurance (QA) for machine oversight and adaptive radiotherapy, as well as AI-assisted treatment planning, to be shown at the 2026 AAPM & COMP Annual Meeting, July 19–21 in Vancouver. Centered on the theme of Next-Gen Innovations for Next-Level Physics, the Sun Nuclear exhibit reflects a focus on smart, practical tools that support medical physics teams to operate with greater efficiency and confidence. Attendees can visit booth 800 for live demos and in-booth presentations and learn more at the Sun Nuclear-hosted lunch symposium.

One Device for Smarter Daily QA

Featured in the Sun Nuclear booth, the new Daily QA™ 4 Pro enables a shift toward more integrated machine QA. Daily QA 4 Pro consolidates dosimetry and imaging checks into a single indexed, imageable solution — reducing room entries, minimizing setup time, and standardizing execution across users. Integrated with the SunCHECK^® Platform, it automates analysis and reporting, so physics teams spend less time on logistics and more time on patient care.

Clinical presentations from Maria Bellon, M.S., DABR, Cedars-Sinai Medical Center, and David Barbee, Ph.D., NYU Langone Health, will offer first-hand perspectives on Daily QA 4 Pro's clinical impact.

Predictive Intelligence for Better Plans, Faster

Plan AI™ enables dosimetrists to deliver higher-quality, patient-specific plans, faster. By leveraging FDA-cleared AI models to predict dose-volume outcomes before planning begins, Plan AI significantly streamlines workflow and peer review.

Professor Todd McNutt, M.S., Ph.D., Director of Clinical Informatics at Johns Hopkins, will present at both the Sunday Lunch Symposium and a Monday in-booth session, sharing how Plan AI is reshaping planning workflows in clinical practice with Artificial Intelligence.

Independent Verification Built for Adaptive Therapy

As online adaptive radiotherapy continues to expand across clinics, AdaptCHECK™ offers purpose-built independent plan verification. Clinical experiences will be featured in dedicated in-booth sessions.

Lunch Symposium — Sunday, July 19 | 12:15 PM | Innovation Room

Sun Nuclear will host a lunch symposium highlighting the latest innovations, including Plan AI, Daily QA 4 Pro, and AdaptCHECK. Space is limited — registration available at sunnuclear.com/aapm.

“At Sun Nuclear, we’re developing the next generation of physics solutions to transform patient treatment through higher levels of excellence in medical physics,” said Luis Rivera, Executive Vice President for Mirion Medical. “The innovations we’re bringing to AAPM 2026 reflect our commitment to giving physics teams the tools they need to reach new levels of precision, performance, and patient impact.”

Pre-book a demo or sign up for talks at sunnuclear.com/aapm.

About Sun Nuclear

Sun Nuclear is part of Mirion Medical, a group of healthcare-focused brands within Mirion, providing innovative solutions for Radiation Therapy and Diagnostic Imaging. More than 6,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, Sun Nuclear aims to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety. Learn more: sunnuclear.com.

Sun Nuclear, Daily QA 4 Pro, Plan AI, AdaptCHECK and SunCHECK are trademarks or registered trademarks of Mirion Technologies, Inc. and/or its affiliates in the United States and/or other countries. All other trademarks are the property of their respective owners.